Cargando…
Immune mechanisms in fibrotic pulmonary sarcoidosis
Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted area. Consequently, there has been little change in the clinical management of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879330/ https://www.ncbi.nlm.nih.gov/pubmed/36543347 http://dx.doi.org/10.1183/16000617.0178-2022 |
_version_ | 1784878664694890496 |
---|---|
author | Weeratunga, Praveen Moller, David R. Ho, Ling-Pei |
author_facet | Weeratunga, Praveen Moller, David R. Ho, Ling-Pei |
author_sort | Weeratunga, Praveen |
collection | PubMed |
description | Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted area. Consequently, there has been little change in the clinical management of fibrotic sarcoidosis over the decades and an unfocused search for new therapeutics. In this review, we provide a comprehensive examination of the relevant immune findings in fibrotic and/or progressive pulmonary sarcoidosis and propose a unifying mechanism for the pathobiology of fibrosis in sarcoidosis. |
format | Online Article Text |
id | pubmed-9879330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-98793302023-01-31 Immune mechanisms in fibrotic pulmonary sarcoidosis Weeratunga, Praveen Moller, David R. Ho, Ling-Pei Eur Respir Rev Reviews Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted area. Consequently, there has been little change in the clinical management of fibrotic sarcoidosis over the decades and an unfocused search for new therapeutics. In this review, we provide a comprehensive examination of the relevant immune findings in fibrotic and/or progressive pulmonary sarcoidosis and propose a unifying mechanism for the pathobiology of fibrosis in sarcoidosis. European Respiratory Society 2022-12-21 /pmc/articles/PMC9879330/ /pubmed/36543347 http://dx.doi.org/10.1183/16000617.0178-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by/4.0/This version is distributed under the terms of the Creative Commons Attribution Licence 4.0. |
spellingShingle | Reviews Weeratunga, Praveen Moller, David R. Ho, Ling-Pei Immune mechanisms in fibrotic pulmonary sarcoidosis |
title | Immune mechanisms in fibrotic pulmonary sarcoidosis |
title_full | Immune mechanisms in fibrotic pulmonary sarcoidosis |
title_fullStr | Immune mechanisms in fibrotic pulmonary sarcoidosis |
title_full_unstemmed | Immune mechanisms in fibrotic pulmonary sarcoidosis |
title_short | Immune mechanisms in fibrotic pulmonary sarcoidosis |
title_sort | immune mechanisms in fibrotic pulmonary sarcoidosis |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879330/ https://www.ncbi.nlm.nih.gov/pubmed/36543347 http://dx.doi.org/10.1183/16000617.0178-2022 |
work_keys_str_mv | AT weeratungapraveen immunemechanismsinfibroticpulmonarysarcoidosis AT mollerdavidr immunemechanismsinfibroticpulmonarysarcoidosis AT holingpei immunemechanismsinfibroticpulmonarysarcoidosis |